FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a ...

A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles ...

Overall, analysts tracked by FactSet expect UnitedHealth to post $101.6 billion in revenue, up from $94.4 billion a year prior. Analysts also model $6.73 in adjusted earnings per share, up from $6.16 ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

The FTC claims that the prices of some specialty drugs used to treat conditions such as cancer or HIV are being marked up as ...

The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs by $7.3 billion over six years.

CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...